Interventions for treating oral leukoplakia (Q24243783)

2

0 references

Cristina Bez

3

0 references

Federica Demarosi

4

0 references

Antonio Carrassi

Cochrane Database of Systematic Reviews

5

0 references

publication date

18 October 2006

0 references

published in

0 references

cites work

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

bcl-2 expression and apoptotic bodies in 13-cis-retinoic acid (isotretinoin)-topically treated oral leukoplakia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Response of oral leukoplakias to the administration of vitamin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Oral leukoplakia: open trial of topical therapy with calcipotriol compared with tretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Evaluation of chemoprevention of oral cancer with Spirulina fusiformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Cytologic and DNA-cytometric follow-up of oral leukoplakia after CO2- and Er:YAG-laser assisted ablation: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

HPV DNA in clinically different variants of oral leukoplakia and lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Clinical risk factors of oral leukoplakia in a representative sample of the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

How to read a paper. The Medline database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Observer variability in the histologic assessment of oral premalignant lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Management of potentially malignant oral mucosal lesions by consultant UK oral and maxillofacial surgeons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Incidence rates for oral leukoplakia and lichen planus in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Pooled estimate of world leukoplakia prevalence: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Is there a natural limit of the transformation rate of oral leukoplakia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

ABC of oral health. Oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Loss of heterozygosity: a potential tool in management of oral premalignant lesions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Oral leukoplakia and malignant transformation. A follow-up study of 257 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Topical bleomycin treatment of oral leukoplakia: a randomized double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Lack of molecular markers to predict malignant potential of oral precancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Leukoplakia of oral mucosa: pathogenesis and possible correction with phytoadaptogen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

A case study of nutrient intervention of oral precancerous lesions in India

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Efficacy of oral lycopene in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Long-term treatment outcome of oral premalignant lesions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Oral epithelial dysplasia and the development of invasive squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Oral mucosal lesions in a representative cross-sectional study of aging Germans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Acitretin and treatment of the oral leucoplakias. A model to have an active molecules release

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Expression of concern: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. the influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001829.PUB3

7 January 2021

10.1002/14651858.CD001829.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1047340

1047340

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference